stockrowHims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Revenue growth
Hims & Hers Health, Inc.'s revenue growth over the twelve months to 30 June 2026 was 28.0%, down 31.0 percentage points from fiscal 2025 (59.0%). Over the past ten years it has ranged from −44.5% (fiscal 2019) to 93.8% (fiscal 2022); the current reading is higher than 20% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 5.22% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 59.0% | (10.33) |
| FY2024 | 69.3% | 3.84 |
| FY2023 | 65.5% | (28.32) |
| FY2022 | 93.8% | 0.00 |
| FY2022 | 93.8% | 11.04 |
| FY2021 | 82.8% | 0.00 |
| FY2021 | 82.8% | 2.59 |
| FY2020 | 80.2% | 0.00 |
| FY2020 | 80.2% | 124.68 |
| FY2019 | −44.5% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 38.3% | 34.48 |
| Mar 2026 | 3.77% | (24.64) |
| Dec 2025 | 28.4% | (20.75) |
| Sep 2025 | 49.2% | (23.45) |
| 22 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| LQDA Liquidia Corporation compare | 2,233.7% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 58.2% |
| HIMS Hims & Hers Health, Inc. | 28.0% |
| SUPN Indivior Pharmaceuticals Inc. compare | 16.4% |
| ALKS Alkermes plc compare | 15.3% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 8.88% |
| LNTH Lantheus Holdings, Inc. compare | 2.38% |
| RDY Dr. Reddy's Laboratories Ltd compare | −15.5% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −77.1% |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- The full statement